Despite a worldwide race to develop a COVID-19 vaccine, China’s CanSino Biologics didn’t make huge headlines when it announced last week that its COVID-19 vaccine candidate had be …
( read original story …)
Home NEWS CanSino’s COVID-19 Vaccine Was Just Approved for Limited Use in China. Here’s What Investors Should Know.
Categories
Beijing
22°
overcast clouds
humidity: 21%
wind: 1m/s SW
H 22 • L 20
Weather from OpenWeatherMap
Recent Posts
- Is China the target of new US global cyberspace and digital technology strategy? 07/05/2024
- China stocks edge down; HK shares fall after 10-day winning streak 07/05/2024
- Humedix signs Chinese marketing deal for Elravie brand 07/05/2024
- China signs MOU with Airbus to deepen aviation cooperation, state media says 07/05/2024
- Two dead, 21 injured in hospital knife attack in China 07/05/2024
- America’s China Strategy Has a Credibility Problem 07/05/2024
- We can’t rely on China to stop the fentanyl crisis 07/05/2024
- China banks’ $900 bln buffer offers sham comfort 07/05/2024
- Exclusive-China’s Nio turns to rival BYD to power new EV brand, sources say 07/05/2024
- China property: Shenzhen, Wuhan are the latest cities to ease housing market restrictions to stir demand 07/05/2024
- China’s Xi Begins Serbia Visit on the 25th Anniversary of NATO’s Bombing of the Chinese Embassy 07/05/2024
- Australia accuses China of unsafe behavior when fighter jet released flares in a helicopter’s path 07/05/2024